Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)

NCT02412696 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 262

Last updated 2024-11-22

No results posted yet for this study

Summary

This study is testing the hypothesis of whether continuous positive airway pressure (CPAP) therapy improves placental histopathology and secretory function. The main aims of the study are to identify shared mechanisms between obstructive sleep apnea and preeclampsia, both common highly morbid conditions.

Conditions

Interventions

DEVICE

Positive Airway Pressure

Auto-titrating PAP + nasal dilator strips during sleep

OTHER

Nasal Dilator Strips

Nasal dilator strips

Sponsors & Collaborators

  • Brown University

    collaborator OTHER
  • Rhode Island Hospital

    collaborator OTHER
  • Women and Infants Hospital of Rhode Island

    collaborator OTHER
  • Brigham and Women's Hospital

    collaborator OTHER
  • The Miriam Hospital

    lead OTHER

Principal Investigators

  • Ghada Bourjeily, MD · The Miriam Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-01
Primary Completion
2020-08-01
Completion
2025-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02412696 on ClinicalTrials.gov